监管灵活性影响瑞/生物科技的BNT162b2 mRNA COVID-19疫苗的审查时间表:一项回顾性研究
Prisha Patel1, Judith C Macdonald1, Jayanthi Boobalan2
1International Regulatory Science and Policy, Pfizer, Tadworth, United Kingdom.
Frontiers in medicine
|November 29, 2023
概括
监管灵活性,包括依赖,加速了全球对瑞/生物科技COVID-19疫苗的审查. 这证明了它们在更快地提供关键药物的价值,而不会牺牲安全性或疗效.
科学领域:
- 监管科学 监管科学
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 监管灵活性可以提高药物和疫苗批准的效率和速度.
- 随着COVID-19的流行,监管过程的快速适应变得越来越重要.
- 确保关键药物的供应和批准新的药物需要迅速采取监管行动.
研究的目的:
- 分析监管灵活性对 Pfizer/BioNTech mRNA COVID-19 疫苗审查和批准时间表的影响.
- 评估监管依赖在全球审批过程中的作用.
- 提供支持更广泛实施监管敏捷性的证据.
主要方法:
- 这是一项回顾性研究,分析了BNT162b2 mRNA COVID-19 疫苗的全球监管批准数据.
- 包括来自73个国家/地区批准的数据.
- 评估依赖方法和特定监管灵活性对审查时间的影响.
主要成果:
- 发现监管灵活性和依赖方法可以显著减少COVID-19疫苗的审查时间.
- 有证据表明,这些方法不会影响疫苗的质量,安全性或疗效.
- 该研究确定了73项全球批准,突出了这些流程的广泛应用.
结论:
- 监管灵活性,特别是依赖,有助于加快疫苗审查.
- 广泛实施监管灵活性可以通过更快地获得基本医疗产品来改善公共卫生结果.
- 这些发现支持继续使用和扩展适应性监管策略.
更多相关视频
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
161
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
161


